Entry
Name
NRG-ERBB2/ERBB3 pathway (RAS-ERK signaling)
Definition
NRG -- ERBB3 -- ERBB2 -> (SHC+GRB2) -> SOS -> RAS -> RAF -> MEK -> ERK
Expanded
(3084,9542) -- 2065 -- 2064 -> (6464+2885) -> (6654,6655) -> (3265,3845,4893) -> (369,673,5894) -> (5604,5605) -> (5594,5595)
Class
Type
Reference
Pathway
Gene
2065 ERBB3; erb-b2 receptor tyrosine kinase 3
2064 ERBB2; erb-b2 receptor tyrosine kinase 2
6464 SHC1; SHC adaptor protein 1
2885 GRB2; growth factor receptor bound protein 2
6654 SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1
6655 SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2
3265 HRAS; HRas proto-oncogene, GTPase
3845 KRAS; KRAS proto-oncogene, GTPase
4893 NRAS; NRAS proto-oncogene, GTPase
369 ARAF; A-Raf proto-oncogene, serine/threonine kinase
673 BRAF; B-Raf proto-oncogene, serine/threonine kinase
5894 RAF1; Raf-1 proto-oncogene, serine/threonine kinase
5604 MAP2K1; mitogen-activated protein kinase kinase 1
5605 MAP2K2; mitogen-activated protein kinase kinase 2
5594 MAPK1; mitogen-activated protein kinase 1
5595 MAPK3; mitogen-activated protein kinase 3
Reference
Authors
Black LE, Longo JF, Carroll SL
Title
Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia.
Journal
Reference
Authors
Zhang C, Mei W, Zeng C
Title
Oncogenic Neuregulin 1 gene (NRG1) fusions in cancer: A potential new therapeutic opportunities.
Journal
Reference
Authors
Kucharczyk T, Nicos M, Kucharczyk M, Kalinka E
Title
NRG1 Gene Fusions-What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications.
Journal
LinkDB
All DBs